DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▲ |
---|---|---|---|---|---|
C0030567 | Parkinson Disease | ELOVL7 | 79993 | ELOVL fatty acid elongase 7 | A1L3X0 |
C0162836 | Hidradenitis Suppurativa | ELOVL7 | 79993 | ELOVL fatty acid elongase 7 | A1L3X0 |
C0027651 | Neoplasms | ELOVL7 | 79993 | ELOVL fatty acid elongase 7 | A1L3X0 |
C0037019 | Shy-Drager Syndrome | ELOVL7 | 79993 | ELOVL fatty acid elongase 7 | A1L3X0 |
C0600139 | Prostate carcinoma | ELOVL7 | 79993 | ELOVL fatty acid elongase 7 | A1L3X0 |
C0376358 | Malignant neoplasm of prostate | ELOVL7 | 79993 | ELOVL fatty acid elongase 7 | A1L3X0 |
C0021390 | Inflammatory Bowel Diseases | ELOVL7 | 79993 | ELOVL fatty acid elongase 7 | A1L3X0 |
C0393571 | Multiple System Atrophy | ELOVL7 | 79993 | ELOVL fatty acid elongase 7 | A1L3X0 |
C3714756 | Intellectual Disability | MACROD2 | 140733 | mono-ADP ribosylhydrolase 2 | A1Z1Q3 |
C0004352 | Autistic Disorder | MACROD2 | 140733 | mono-ADP ribosylhydrolase 2 | A1Z1Q3 |
C0345904 | Malignant neoplasm of liver | MACROD2 | 140733 | mono-ADP ribosylhydrolase 2 | A1Z1Q3 |
C0028754 | Obesity | MACROD2 | 140733 | mono-ADP ribosylhydrolase 2 | A1Z1Q3 |
C0010346 | Crohn Disease | MACROD2 | 140733 | mono-ADP ribosylhydrolase 2 | A1Z1Q3 |
C1510586 | Autism Spectrum Disorders | MACROD2 | 140733 | mono-ADP ribosylhydrolase 2 | A1Z1Q3 |
C0005586 | Bipolar Disorder | MACROD2 | 140733 | mono-ADP ribosylhydrolase 2 | A1Z1Q3 |
C0038580 | Substance Dependence | MACROD2 | 140733 | mono-ADP ribosylhydrolase 2 | A1Z1Q3 |
C0699790 | Colon Carcinoma | MACROD2 | 140733 | mono-ADP ribosylhydrolase 2 | A1Z1Q3 |
C0796004 | Kabuki make-up syndrome | MACROD2 | 140733 | mono-ADP ribosylhydrolase 2 | A1Z1Q3 |
C0013170 | Drug habituation | MACROD2 | 140733 | mono-ADP ribosylhydrolase 2 | A1Z1Q3 |
C0025362 | Mental Retardation | MACROD2 | 140733 | mono-ADP ribosylhydrolase 2 | A1Z1Q3 |
C0013222 | Drug Use Disorders | MACROD2 | 140733 | mono-ADP ribosylhydrolase 2 | A1Z1Q3 |
C0019693 | HIV Infections | MACROD2 | 140733 | mono-ADP ribosylhydrolase 2 | A1Z1Q3 |
C0006826 | Malignant Neoplasms | MACROD2 | 140733 | mono-ADP ribosylhydrolase 2 | A1Z1Q3 |
C0334463 | Malignant Fibrous Histiocytoma | MACROD2 | 140733 | mono-ADP ribosylhydrolase 2 | A1Z1Q3 |
C0236969 | Substance-Related Disorders | MACROD2 | 140733 | mono-ADP ribosylhydrolase 2 | A1Z1Q3 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024